| Dr Kendra Fajardo, AUD | |
|
1008 N 7th Ave Ste H, Bozeman, MT 59715-2567 | |
| (406) 586-0914 | |
| Not Available |
| Full Name | Dr Kendra Fajardo |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 1008 N 7th Ave Ste H, Bozeman, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649919721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | SLP-AU-LIC-10628 (Montana) | Primary |
| Provider Name | Helton Hearing, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1558684464 PECOS PAC ID: 5193852218 Enrollment ID: O20100422000054 |
News Archive
Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter's recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
Inappropriate activation of a single enzyme, telomerase, is associated with the uncontrollable proliferation of cells seen in as many as 90 percent of all of human cancers. Since the mid-1990s, when telomerase was first identified in human tumors, scientists have eyed the enzyme as an ideal target for developing broadly effective anti-cancer drugs.
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
Neurosurgeons at UC San Diego Heath System have, for the first time, combined real-time magnetic resonance imaging (MRI) technology with novel non-invasive cellular mapping techniques to develop a new biopsy approach that increases the accuracy of diagnosis for patients with brain cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kendra Fajardo, AUD 1008 N 7th Ave Ste H, Bozeman, MT 59715-2567 Ph: (406) 586-0914 | Dr Kendra Fajardo, AUD 1008 N 7th Ave Ste H, Bozeman, MT 59715-2567 Ph: (406) 586-0914 |
News Archive
Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter's recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall.
Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.
Inappropriate activation of a single enzyme, telomerase, is associated with the uncontrollable proliferation of cells seen in as many as 90 percent of all of human cancers. Since the mid-1990s, when telomerase was first identified in human tumors, scientists have eyed the enzyme as an ideal target for developing broadly effective anti-cancer drugs.
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
Neurosurgeons at UC San Diego Heath System have, for the first time, combined real-time magnetic resonance imaging (MRI) technology with novel non-invasive cellular mapping techniques to develop a new biopsy approach that increases the accuracy of diagnosis for patients with brain cancer.
› Verified 7 days ago
Marci Kim Lund, AU.D., F-AAA, CCC- Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1008 N 7th Ave Ste H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 | |
Ryanne Tindell, AU.D. Audiologist Medicare: May Accept Medicare Assignments Practice Location: 1008 N 7th Ave Ste H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 | |
Katelyn Ellen Thompson, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1008 N 7th Ave Ste H, Bozeman, MT 59715 Phone: 406-586-0914 | |
Jennifer D Sabers, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 925 Highland Blvd, Suite 1160, Bozeman, MT 59715 Phone: 406-587-5000 Fax: 406-585-5068 | |
Helton Hearing Care Audiologist Medicare: Medicare Enrolled Practice Location: 1008 N. 7th Ave., Suite H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 | |
Alyson Renee Holmes, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1008 N 7th Ave, Suite H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 | |
Dr. William M Helton Iii, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1008 N 7th Ave, Suite H, Bozeman, MT 59715 Phone: 406-586-0914 Fax: 406-586-6667 |